Riskpilot← Back to searchSign inGet full accessDr Ulrika AB
ABActiveOrg 5590202247Dvärsättsvägen 2General medical practice activities · NACE 8621Est. 20150 employees
Revenue 2025
SEK 104K
-52% vs 2024
EBITDA margin
82.0%
-50% vs 2024
Equity ratio
94.7%
Financial strength
Net profit 2025
SEK 68K
-54% vs 2024
| Revenue | SEK 104K | -52% |
| EBITDA | SEK 85K | -50% |
| Net profit | SEK 68K | -54% |
| Total assets | SEK 447K | +9% |
| Equity | SEK 423K | +19% |
| Employees | 0 | — |
Legal name
Dr Ulrika AB
Org number
5590202247
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
8 juli 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet inom allmänmedicin, folkhälsa, ledarskap och organisation. Uthyrning av sjukvårdspersonal. Kursverksamhet inom sjukvård, friskvård, friluftsliv, ledarskap, handledning, konsultation och organisation. Forskning och innovationsverksamhet. Produktutveckling inom sjukvård, medicin, sport- och friluftsliv samt IT. Eventverksamhet. Fastighetsförvaltning. Handel med värdepapper.
Address
Dvärsättsvägen 2
Email
drulrikaab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | 168 | 15 | 216 | 104 |
| Staff expenses | — | — | — | −24 | −10 |
| EBITDA | 0 | 124 | −2 | 169 | 85 |
| Depreciation & amort. | — | −0 | −0 | — | — |
| EBIT | 0 | 124 | −2 | 169 | 85 |
| Net financials | — | — | — | 17 | 0 |
| Profit before tax | 0 | 124 | −2 | 186 | 85 |
| Tax | — | −26 | −0 | −38 | −18 |
| Net profit | — | 98 | −2 | 148 | 68 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | — | 803 | 407 | 410 | 447 |
| Equity | — | 785 | 407 | 355 | 423 |
| Long-term debt | — | 0 | 0 | — | — |
| Short-term debt | — | 18 | 0 | 55 | 24 |
| Total debt | — | 18 | — | 55 | 24 |
EBITDA margin
82.0%
This company
15.8%
Market median
+419% vs market
20212025
Equity ratio
94.7%
This company
38.2%
Market median
+148% vs market
20212025
Return on equity
16.0%
This company
18.4%
Market median
+13% vs market
20212025
Net profit margin
65.4%
This company
8.1%
Market median
+707% vs market
20212025
Asset turnover
0.23×
This company
1.12×
Market median
-79% vs market
20212025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Ulrika AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Viveka Sofia Viktoria Elmroth | Deputy Board Member | 0 companies |
| Signe Mia Ulrika Elmroth | Board of Directors | 0 companies |